Glenmark Q3 revenue up 118%, net at Rs 189cr

Glenmark Pharmaceuticals today reported a consolidated net profit of Rs 188.98 crore for the third quarter ended December 31, 2006. Consolidated revenue was up 118% at Rs 446.12 crore.

Following is the press release issued by the company today:

Mumbai, January 23, 2007: Glenmark Pharmaceuticals Limited, the research-led global and integrated pharmaceutical company, has posted gross [total] consolidated revenues of Rs. 4461.22 Mn [USD  99.13 Mn] for the third quarter of the financial year 2006-07 ended December 31, 2006 and a growth of 118% compared to the corresponding period of the previous year.  Consolidated profits for the quarter were Rs. 1889.82 million [USD 42.00 Mn]; while the net profit from the base business [net of milestones] stood at Rs. 615.93 Mn [USD 13.69 Mn].   

Formulations: In the period under review, Glenmark